Equities

Wellness Center USA Inc

WCUI:PKL

Wellness Center USA Inc

Actions
  • Price (USD)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded12.58k
  • 1 Year change-68.75%
  • Beta1.6848
Data delayed at least 15 minutes, as of Jun 24 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wellness Center USA, Inc., through its subsidiaries, is engaged in the healthcare and medical sectors. The Company’s segments include Medical Devices and Authentication and Encryption Products and Services. The segments are operated through Psoria-Shield Inc. (PSI) and StealthCo Inc. (SCI). PSI designs, develops, and markets a targeted UV phototherapy device called the Psoria-Light. The Psoria-Light is designated for use in targeted PUVA photochemistry and UVB phototherapy and is designed to treat certain skin conditions, including psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma. SCI is a provider of Stealth Mark encryption and authentication solutions offering advanced technologies within the security and supply chain management vertical sectors (Intelligent Microparticles), and advanced data intelligence services offering technology for industries, companies, and agencies on a global scale (ActiveDuty).

  • Revenue in USD (TTM)391.23k
  • Net income in USD-1.19m
  • Incorporated2010
  • Employees4.00
  • Location
    Wellness Center USA Inc2500 West Higgins Road, Ste. 780HOFFMAN ESTATES 60169United StatesUSA
  • Phone+1 (847) 925-1885
  • Fax+1 (847) 925-1859
  • Websitehttps://wellnesscenterusa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wellness Center USA Inc391.23k-1.19m57.80k4.00------0.1477-0.0092-0.00920.0031-0.02492.231.10-----892.24-2,092.00----67.8137.82-399.36-1,462.730.011-1.95----4,699.20-4.3463.70------
Prosomnus Inc29.30m-18.69m69.58k136.00------0.0024-1.15-1.151.70-1.311.1210.588.37215,453.20-52.46---458.34--49.77---46.97--0.2471-3.003.82--42.59---237.21------
G Medical Innovations Holdings Ltd-100.00bn-100.00bn229.95k----0.0011----------8.78------------------------1.52--0.306--80.47--7.68------
Motus GI Holdings Inc327.00k-16.10m236.52k15.00--0.0697--0.7233-12.68-12.680.11340.58860.03391.184.9221,800.00-109.80-80.63-182.50-112.32-24.46-44.53-3,239.76-6,160.581.67-13.010.4287---46.1154.7030.81---28.25--
Data as of Jun 24 2024. Currency figures normalised to Wellness Center USA Inc's reporting currency: US Dollar USD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Associated Trust Co., N.A. (Wisconsin Investment Management)as of 31 Mar 202412.50k0.01%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.